The PROSPECT II study was published in the March 13th issue of The Lancet,
finding that IVUS+NIRS imaging can detect plaques at increased risk for future adverse cardiac outcomes.VIEW ARTICLE VIEW ARTICLE

Reduce blood loss with the OKAY® II Y-Connector

NOW AVAILABLE IN THE USA
#1 selling Y-Connector in Japan
View Product Details Start a Free Trial

Logo

Now FDA indicated to identify plaque and patients at increased risk of MACE.

Achieve unparalleled insights with the Makoto™ Imaging System and its accompanying Dualpro™ IVUS + NIRS catheter, the only FDA-cleared dual-modality catheter and imaging system indicated for the identification of patients and plaques at increased risk of major adverse cardiac events (MACE).

Explore the

LRP STUDY RESULTS

 

See the Makoto™

SYSTEM IN ACTION

 

Discover the

IVUS+NIRS TECHNOLOGY

 

We are Pioneers

developing solutions aimed at conquering vascular disease

SEE WHAT IT TAKES

© 2020 Infraredx™, Inc. All Rights Reserved Powered by Bloom Creative